The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: olanzapine     Quarter: 2016Q3

Total Records: 887     Number of Pages: 45

DRUGNAME PT EventCount
OLANZAPINE. Total cholesterol/HDL ratio increased 2
OLANZAPINE. Troponin I increased 2
OLANZAPINE. Vaginal infection 2
OLANZAPINE. White blood cell count decreased 2
Olanzapine (Unknown) Acute kidney injury 1
Olanzapine (Unknown) Drug level increased 1
Olanzapine (Unknown) Eosinophilic myocarditis 1
Olanzapine (Unknown) Extra dose administered 1
Olanzapine (Unknown) Heat stroke 1
Olanzapine (Unknown) Medication error 1
Olanzapine (Unknown) Pneumonia aspiration 1
Olanzapine (Unknown) Prescribed overdose 1
Olanzapine (Unknown) Sudden cardiac death 1
Olanzapine (Unknown) Toxicity to various agents 1
Olanzapine 10mg Acute kidney injury 1
Olanzapine 10mg Agoraphobia 1
Olanzapine 10mg Cardiomyopathy 1
Olanzapine 10mg Condition aggravated 1
Olanzapine 10mg Cytomegalovirus enterocolitis 1
Olanzapine 10mg Dehydration 1

Total Records: 887     Number of Pages: 45